These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7694293)

  • 1. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.
    Dawson TM; Steiner JP; Dawson VL; Dinerman JL; Uhl GR; Snyder SH
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9808-12. PubMed ID: 7694293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition.
    Macleod MR; Butcher SP
    Neurosci Lett; 2002 Mar; 322(1):41-4. PubMed ID: 11958839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture.
    Kikuchi M; Kashii S; Mandai M; Yasuyoshi H; Honda Y; Kaneda K; Akaike A
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1227-32. PubMed ID: 9620083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism by NG-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy.
    Vigé X; Carreau A; Scatton B; Nowicki JP
    Neuroscience; 1993 Aug; 55(4):893-901. PubMed ID: 7694182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various nitric oxide synthase inhibitors on NMDA-induced neuronal injury in rat cortical neurons.
    Wang JY; Chi SI; Wang JY; Hwang CP; Wang JY
    Chin J Physiol; 1996; 39(4):227-33. PubMed ID: 9058007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice.
    Dawson VL; Kizushi VM; Huang PL; Snyder SH; Dawson TM
    J Neurosci; 1996 Apr; 16(8):2479-87. PubMed ID: 8786424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophilin regulation of neurotransmitter release.
    Steiner JP; Dawson TM; Fotuhi M; Snyder SH
    Mol Med; 1996 May; 2(3):325-33. PubMed ID: 8784785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
    Dawson VL; Dawson TM; London ED; Bredt DS; Snyder SH
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6368-71. PubMed ID: 1648740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural roles of immunophilins and their ligands.
    Sabatini DM; Lai MM; Snyder SH
    Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modification of glutamate neurotoxicity in vivo.
    Fujisawa H; Dawson D; Browne SE; MacKay KB; Bullock R; McCulloch J
    Brain Res; 1993 Nov; 629(1):73-8. PubMed ID: 7506985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of excitatory neurotransmitter-nitric oxide signaling pathway by inhalational anesthetics.
    Zuo Z; Tichotsky A; Johns RA
    Neuroscience; 1999; 93(3):1167-72. PubMed ID: 10473281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.
    Dawson VL; Dawson TM; Bartley DA; Uhl GR; Snyder SH
    J Neurosci; 1993 Jun; 13(6):2651-61. PubMed ID: 7684776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase.
    Samdani AF; Newcamp C; Resink A; Facchinetti F; Hoffman BE; Dawson VL; Dawson TM
    J Neurosci; 1997 Jun; 17(12):4633-41. PubMed ID: 9169524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium and zinc potentiate ethanol inhibition of N-methyl-D-aspartate-stimulated nitric oxide synthase in cortical neurons.
    Chandler LJ; Guzman NJ; Sumners C; Crews FT
    J Pharmacol Exp Ther; 1994 Oct; 271(1):67-75. PubMed ID: 7525932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes.
    Kaibori M; Sakitani K; Oda M; Kamiyama Y; Masu Y; Nishizawa M; Ito S; Okumura T
    J Hepatol; 1999 Jun; 30(6):1138-45. PubMed ID: 10406194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
    Schwaninger M; Blume R; Oetjen E; Knepel W
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ethanol increases N-methyl-D-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons.
    Chandler LJ; Sutton G; Norwood D; Sumners C; Crews FT
    Mol Pharmacol; 1997 May; 51(5):733-40. PubMed ID: 9145911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of involvement of nitric oxide in NMDA-induced neuronal cell death in cortical culture.
    Zinkand WC; Stumpo RJ; Thompson C; Patel J; Pullan LM
    Neuroreport; 1993 Nov; 5(2):148-50. PubMed ID: 7509205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
    Dusting GJ; Akita K; Hickey H; Smith M; Gurevich V
    Br J Pharmacol; 1999 Sep; 128(2):337-44. PubMed ID: 10510443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine.
    Li W; Lee NT; Fu H; Kan KK; Pang Y; Li M; Tsim KW; Li X; Han Y
    Neuroreport; 2006 Apr; 17(5):471-4. PubMed ID: 16543809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.